NCT05969002 2026-03-18
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
National Institutes of Health Clinical Center (CC)
Completed
Clinical Trials
541 trialsNCT01563874 2026-03-11
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
National Institutes of Health Clinical Center (CC)
Completed
NCT04319237 2026-03-02
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT03751072 2026-02-27
FRENCH-CYTO
Group for Research in Adult Acute Lymphoblastic Leukemia
Completed
NCT07439835 2026-02-27
IOL-VAC
Democritus University of Thrace
Completed
NCT00339963 2026-02-20
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
National Institutes of Health Clinical Center (CC)
Completed
NCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
NCT06578351 2026-02-04
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
Completed
NCT05622682 2026-01-26
VIRAL
Children's Hospital of Philadelphia
Completed
NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
NCT04600804 2025-12-24
The Role of 18F-FDG-PET for Staging and Prognostication
Fondazione Italiana Linfomi - ETS
Completed
NCT06113081 2025-12-24
FIL_MOGA
Fondazione Italiana Linfomi - ETS
Completed
NCT04913038 2025-12-19
ANI-EP
University Hospital, Lille
Completed
NCT06471660 2025-12-18
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
University of Oregon
Completed
NCT05923112 2025-12-05
BESPONSA Injection 1 mg Special Investigation
Pfizer
Completed
NCT04178317 2025-12-04
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
AbbVie
Completed
NCT03898128 2025-12-03
INO-CD22
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Completed
NCT04830046 2025-11-26
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Massachusetts General Hospital
Completed
NCT06362044 2025-11-25
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
AbbVie
Completed
NCT07145125 2025-11-21
HL-R2-B2
University Hospital, Bordeaux
Completed
NCT02827617 2025-11-18
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
Oncology Institute of Southern Switzerland
Completed
NCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT03521596 2025-11-18
FIL_BIOWM
Fondazione Italiana Linfomi - ETS
Completed
NCT03816683 2025-11-14
SUMMIT
AstraZeneca
Completed
NCT03838627 2025-11-12
Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)
St. Jude Children's Research Hospital
Completed
NCT06244147 2025-11-06
Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults
SF Research Institute, Inc.
Completed
NCT04188678 2025-10-27
REBOUND
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT06449924 2025-10-01
An Endotracheal Tube Inserted to the Level of the Hypopharynx
American University of Beirut Medical Center
Completed
NCT05212233 2025-09-26
Financial Difficulty in Patients With Blood Cancer
UNC Lineberger Comprehensive Cancer Center
Completed
NCT06209463 2025-09-26
Posture, Hand Functions and Sensory Processing Skills on Nutrition
Bezmialem Vakif University
Completed
NCT06358001 2025-09-22
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
Completed
NCT06278181 2025-09-03
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
Karolinska Institutet
Completed
NCT04872621 2025-09-02
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation
AstraZeneca
Completed
NCT07150468 2025-09-02
Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
Asan Medical Center
Completed
NCT05123001 2025-08-29
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Stanford University
Completed
NCT07120217 2025-08-13
BRIGHT-MBVD
Federico II University
Completed
NCT06535997 2025-08-06
PRIMHADRON
Hospices Civils de Lyon
Completed
NCT05964322 2025-07-31
RYTHMO'FIT
University Hospital, Montpellier
Completed
NCT05583318 2025-07-23
LymphoVie 2
Centre Hospitalier Universitaire Dijon
Completed
NCT04833504 2025-07-16
Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed
NCT02821793 2025-07-01
PRIORITY
Institut Bergonié
Completed
NCT05555979 2025-06-29
ELECTRIC
AbbVie
Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT05440409 2025-06-26
CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL
National Institutes of Health Clinical Center (CC)
Completed
NCT05827107 2025-06-15
Skin Barrier and Microbiome of CTCL Patients
Centre for Human Drug Research, Netherlands
Completed
NCT06422247 2025-06-04
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
Bristol-Myers Squibb
Completed
NCT06790420 2025-05-31
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Completed
NCT05958134 2025-05-23
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
AstraZeneca
Completed
NCT04938141 2025-05-21
MEOI and HRQoL in CLL Patients Treated With BTKis
AstraZeneca
Completed
NCT00368784 2025-05-14
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
University of California, Davis
Completed